Ospedale Cannizzaro, Università di Catania, Via Antonello da Messina 75, Acicastello, 95021 Catania, Italy.
Ospedale G. Bosco, Torino, Italy.
Eur Heart J. 2015 Dec 1;36(45):3189-98. doi: 10.1093/eurheartj/ehv450. Epub 2015 Sep 2.
Through contemporary literature, the optimal strategy to manage coronary chronic total occlusions (CTOs) remains under debate.
The aim of the Italian Registry of Chronic Total Occlusions (IRCTO) was to provide data on prevalence, characteristics, and outcome of CTO patients according to the management strategy.
The IRCTO is a prospective real world multicentre registry enrolling patients showing at least one CTO. Clinical and angiographic data were collected independently from the therapeutic strategy [optimal medical therapy (MT), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG)]; a comparative 1-year clinical follow-up was performed.
A total of 1777 patients were enrolled for an overall CTO prevalence of 13.3%. The adopted therapeutic strategies were as follows: MT in 826 patients (46.5%), PCI in 776 patients (43.7%), and CABG in the remaining 175 patients (9.8%). At 1-year follow-up, patients undergoing PCI showed lower rate of major adverse cardiac and cerebrovascular events (MACCE) (2.6% vs. 8.2% and vs. 6.9%; P < 0.001 and P < 0.01) and cardiac death (1.4% vs. 4.7% and vs. 6.3%; P < 0.001 and P < 0.001) in comparison with those treated with MT and CABG, respectively. After propensity score-matching analysis, patients treated with PCI showed lower incidence of cardiac death (1.5 vs. 4.4%; P < 0.001), acute myocardial infarction (1.1 vs. 2.9%; P = 0.03), and re-hospitalization (2.3 vs. 4.4% P = 0.04) in comparison with those managed by MT.
Our data showed how CTO PCI might significantly improve the survival and decrease MACCE occurrence at 1 year follow-up in comparison with MT and/or CABG.
通过当代文献,管理冠状动脉慢性完全闭塞(CTO)的最佳策略仍存在争议。
意大利 CTO 注册研究(IRCTO)旨在根据治疗策略提供 CTO 患者的患病率、特征和结局数据。
IRCTO 是一项前瞻性真实世界多中心注册研究,纳入至少有 1 例 CTO 的患者。临床和血管造影数据分别根据治疗策略[最佳药物治疗(MT)、经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)]进行收集;进行了为期 1 年的临床随访。
共纳入 1777 例 CTO 患者,总体 CTO 患病率为 13.3%。采用的治疗策略如下:MT 治疗 826 例(46.5%)、PCI 治疗 776 例(43.7%)和 CABG 治疗 175 例(9.8%)。在 1 年随访时,行 PCI 治疗的患者主要不良心脑血管事件(MACCE)发生率较低(2.6%比 8.2%和 6.9%;P<0.001 和 P<0.01)和心脏死亡(1.4%比 4.7%和 6.3%;P<0.001 和 P<0.001)与 MT 和 CABG 治疗的患者相比。在倾向评分匹配分析后,行 PCI 治疗的患者心脏死亡(1.5%比 4.4%;P<0.001)、急性心肌梗死(1.1%比 2.9%;P=0.03)和再住院(2.3%比 4.4%;P=0.04)发生率较低与 MT 治疗的患者相比。
与 MT 和/或 CABG 相比,我们的数据显示 CTO PCI 可能在 1 年随访时显著改善生存并降低 MACCE 的发生。